Plymouth, MN · Founded 2009 · Privately Held (backing)
Developer of a non-invasive and robotically assisted ultrasound therapy device designed for precise tissue destruction. HistoSonics is based in Plymouth, MN and was founded in 2009. It was valued at $610 million at its later-stage round in Aug 2024, the last priced event on record. It has raised $250 million across 3 recorded rounds; the latest was a $102 million later-stage round in Jul 2024.
PMV mark · valuation
$610.0M
Oct 2026
Priced at
its later-stage round
Aug 2024
Total raised
$250.0M
Last round
Later Stage VC
Jul 2024
No prints on record
No secondary trades in HistoSonics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of HistoSonics with a free account
·The complete investor list: 16 names
·Watch HistoSonics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of HistoSonics stock.
